Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Aug 05, 2021 16:05 ET
BigCommerce Announces Second Quarter Financial Results
BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), a leading Open SaaS ecommerce platform for fast-growing and established brands, today announced financial results for its second quarter ended June 30, 2021. “Q2 concludes our first full...
Aug 05, 2021 16:05 ET
Codexis Reports Second Quarter 2021 Financial Results
Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced financial results for the second quarter ended June 30, 2021 and provided a business update. “Codexis had an...
Aug 05, 2021 16:05 ET
El Pollo Loco Holdings, Inc. Announces Second Quarter 2021 Financial Results
El Pollo Loco Holdings, Inc. (Nasdaq: LOCO) today announced financial results for the 13-week period ended June 30, 2021. Highlights for the second quarter ended June 30, 2021 compared to the second quarter ended June 24, 2020 were...
Aug 05, 2021 16:05 ET
First Eagle Alternative Capital BDC, Inc. Reports Second Quarter 2021 Financial Results and Declares a Dividend of $0.10 Per Share
First Eagle Alternative Capital BDC, Inc. (NASDAQ: FCRD) (“First Eagle Alternative Capital BDC” or the “Company”), a direct lender to middle market companies, today announced financial results for its second fiscal quarter ended June 30, 2021....
Aug 05, 2021 16:05 ET
FreightCar America, Inc. to Release Second Quarter 2021 Results on August 16, 2021
FreightCar America, Inc. (Nasdaq: RAIL) will host a conference call and live webcast on Monday, August 16, 2021 at 11:00 a.m. (Eastern Daylight Time) to discuss the Company’s second quarter 2021 financial results. The Company’s earnings release for...
Aug 05, 2021 16:05 ET
Pyxis Tankers Announces Date for the Release of the Second Quarter 2021 Results and Related Conference Call & Webcast
MAROUSSI, GREECE – August 5, 2021 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), an international pure play product tanker company, today announced the following: Date of Earnings Release. We will issue our unaudited results for the second quarter...
Aug 05, 2021 16:03 ET
Health Catalyst Reports Second Quarter 2021 Results
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2021. “In the second quarter...
Aug 05, 2021 16:02 ET
Appian Announces Second Quarter 2021 Financial Results
Appian (Nasdaq: APPN) today announced financial results for the second quarter ended June 30, 2021. “In Q2, Appian increased cloud subscription revenue by 44% and announced the acquisition of a leading process mining firm. With this acquisition,...
Aug 05, 2021 16:02 ET
Oyster Point Pharma Reports Second Quarter 2021 Financial Results and Recent Business Highlights
Oyster Point Pharma, Inc. (Nasdaq: OYST), (“Oyster Point Pharma” or “the Company”) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic...
Aug 05, 2021 16:02 ET
Sprouts Farmers Market, Inc. Reports Second Quarter 2021 Results
Sprouts Farmers Market, Inc. (Nasdaq: SFM) today reported results for the 13-week second quarter ended July 4, 2021. Second Quarter Highlights(1): Net sales of $1.5 billion; a 7% decrease from the same period in 2020 and a 7% increase from...
Aug 05, 2021 16:02 ET
Sunrun Announces Co-Founder and CEO Lynn Jurich to Transition to Executive Co-Chair of the Board; Mary Powell to Become Company’s Next CEO
Sunrun Inc. (NASDAQ: RUN), the nation's leading provider of residential solar, storage and energy services, today announced that Mary Powell, a Sunrun Director and former President and CEO of Green Mountain Power, will become the Company’s next...
Aug 05, 2021 16:01 ET
Assembly Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights
Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV), today reported financial results and recent highlights for the second quarter ended June 30,...
Aug 05, 2021 16:01 ET
Assertio Reports Second Quarter 2021 Financial Results
Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a leading commercial pharmaceutical company bringing differentiated products to patients, today reported financial results for the second quarter ended June 30, 2021....
Aug 05, 2021 16:01 ET
Celldex Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update. “Last month, Celldex reported positive data from our ongoing Phase 1b study of CDX-0159 in...
Aug 05, 2021 16:01 ET
Clene Nanomedicine Appoints Dr. Vallerie McLaughlin to its Board of Directors
Clene Inc. (NASDAQ: CLNN) along with its subsidiaries “Clene” and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to the treatment of neurodegenerative disease using nanotechnology to treat...
Aug 05, 2021 16:01 ET
Codiak BioSciences Reports Second Quarter 2021 Financial Results and Operational Progress
Codiak BioSciences, Inc. (NASDAQ: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today reported second quarter 2021 financial results and...
Aug 05, 2021 16:01 ET
Coherus BioSciences Reports Second Quarter 2021 Financial Results and Immuno-oncology and Biosimilar Pipeline Progress
Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today reported financial results for the quarter ended June 30, 2021. The Company also provided a progress update on its PD-1 blocking antibody, toripalimab, its lead...
Aug 05, 2021 16:01 ET
Collegium Reports Strong Q2 Results with Cash Balance Growing to Over $200 Million
Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today reported its financial results for the second quarter ended June 30, 2021 and provided a corporate...
Aug 05, 2021 16:01 ET
CymaBay Therapeutics to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021
CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it will host a conference call and live audio...
Aug 05, 2021 16:01 ET
electroCore Announces Second Quarter 2021 Financial Results
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced second quarter 2021 financial results and provided an operational update. Second Quarter 2021 and Recent Highlights                 Posted revenue...